Latest Profitability News

Whitefield Income Limited has reported a $7.8 million net profit in its first seven months as an ASX-listed company, alongside steady monthly dividends annualised at 8%. The company’s portfolio outperformed its benchmark, signaling a promising start post-IPO.

Schaffer Corporation reported a 16% rise in underlying net profit for FY25, driven by strong Automotive Leather and Delta divisions, while maintaining its dividend and appointing a new CEO to steer future growth.

Vicinity Centres reported a robust FY25 with statutory net profit soaring to $1 billion, driven by strategic portfolio repositioning and strong leasing momentum. The company’s focus on premium retail assets and key developments underpin a cautiously optimistic outlook for FY26.

Schaffer Corporation Limited reported a 1.5% increase in revenue to $229.7 million for FY2025, despite a 10.3% decline in net profit to $24.3 million. The company declared a fully franked final dividend of 45 cents per share, maintaining total dividends at 90 cents for the year.

Xamble Group Limited is accelerating its transformation into Southeast Asia’s premier influencer marketing platform, reporting strong H1 revenue growth and launching a strategic rights issue to fund expansion and technology upgrades.

Lycopodium Limited delivered robust FY25 financial results, hitting the top end of guidance with $339.6 million revenue and $42.2 million net profit. The company’s strategic SAXUM acquisition broadens its footprint in the Americas, positioning it well for growth in critical minerals and clean energy sectors.

Pharmx Technologies reported a 13% increase in FY25 revenues to $7.53 million, driven by strong growth across its Gateway and Marketplace platforms. The company maintained positive EBITDA and a solid cash position despite legal expenses, setting the stage for an ambitious FY26 growth strategy.

Vicinity Centres reported a robust FY25 with statutory net profit surpassing $1 billion and Funds From Operations reaching the top end of guidance, underpinned by strategic asset acquisitions and strong portfolio performance.

Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.

Lycopodium Limited delivered FY25 results at the top end of guidance, reporting strong revenue and profit growth alongside strategic moves to deepen its global footprint, notably through the acquisition of Argentinian engineering firm SAXUM.

Pharmx Technologies Limited reported a 13% increase in revenue for FY25, driven by expanded supplier-pharmacy connections and Marketplace platform growth, while profit before tax declined due to significant investments in new technology platforms.

Superloop has reported a robust FY25 with a 31% revenue increase and significant market share gains in the nbn broadband sector, alongside a positive net profit after tax.